Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Cancer Genetics
|
June 17, 2014
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
Miriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Human Molecular Genetics
|
May 16, 2006
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer
George Xinarianos, Fiona E McRonald, Janet M Risk, et al.
Oral Oncology
|
January 30, 2007
CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology
Richard J Shaw, Gillian L Hall, Derek Lowe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2006
Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients
Oliver Gautschi, Barbara Hugli, Annemarie Ziegler, et al.
American Journal of Medical Genetics. Part A
|
November 23, 2011
Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis
Miriam J Smith, Anjana Kulkarni, Cecilie Rustad, et al.
Neurogenetics
|
March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
Miriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
BMJ Case Reports
|
November 20, 2014
A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma
Yoyo Wing-Yiu Chu, Daniel Ka Leung Cheuk, Brian Hon Yin Chung, et al.
Human Mutation
|
June 20, 2022
Screening of potential novel candidate genes in schwannomatosis patients
Cristina Perez-Becerril, Andrew J Wallace, Helene Schlecht, et al.
Human Mutation
|
December 1, 2015
The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes
Miriam J Smith, Jill E Urquhart, Elaine F Harkness, et al.
Cancers
|
February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
Zerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Cancer Genetics
|
June 17, 2014
SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumors
Miriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
Human Molecular Genetics
|
May 16, 2006
Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer
George Xinarianos, Fiona E McRonald, Janet M Risk, et al.
Oral Oncology
|
January 30, 2007
CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology
Richard J Shaw, Gillian L Hall, Derek Lowe, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 13, 2006
Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients
Oliver Gautschi, Barbara Hugli, Annemarie Ziegler, et al.
American Journal of Medical Genetics. Part A
|
November 23, 2011
Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis
Miriam J Smith, Anjana Kulkarni, Cecilie Rustad, et al.
Neurogenetics
|
March 22, 2012
Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis
Miriam J Smith, Andrew J Wallace, Naomi L Bowers, et al.
BMJ Case Reports
|
November 20, 2014
A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma
Yoyo Wing-Yiu Chu, Daniel Ka Leung Cheuk, Brian Hon Yin Chung, et al.
Human Mutation
|
June 20, 2022
Screening of potential novel candidate genes in schwannomatosis patients
Cristina Perez-Becerril, Andrew J Wallace, Helene Schlecht, et al.
Human Mutation
|
December 1, 2015
The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes
Miriam J Smith, Jill E Urquhart, Elaine F Harkness, et al.
Cancers
|
February 13, 2020
Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
Zerin Hyder, Elaine F Harkness, Emma R Woodward, et al.
Page
of 3